A detailed history of Oppenheimer & CO Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 30,265 shares of TMO stock, worth $15.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
30,265
Previous 31,433 3.72%
Holding current value
$15.5 Million
Previous $17.4 Million 7.69%
% of portfolio
0.29%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$531.86 - $624.21 $621,212 - $729,077
-1,168 Reduced 3.72%
30,265 $18.7 Million
Q2 2024

Aug 07, 2024

BUY
$541.52 - $599.02 $77,978 - $86,258
144 Added 0.46%
31,433 $17.4 Million
Q1 2024

May 06, 2024

BUY
$528.82 - $599.43 $350,078 - $396,822
662 Added 2.16%
31,289 $18.2 Million
Q4 2023

Feb 13, 2024

SELL
$431.41 - $532.94 $470,236 - $580,904
-1,090 Reduced 3.44%
30,627 $16.3 Million
Q3 2023

Nov 07, 2023

SELL
$498.29 - $574.41 $485,832 - $560,049
-975 Reduced 2.98%
31,717 $16.1 Million
Q2 2023

Aug 02, 2023

SELL
$508.46 - $591.13 $48,303 - $56,157
-95 Reduced 0.29%
32,692 $17.1 Million
Q1 2023

May 10, 2023

SELL
$535.0 - $604.82 $2.11 Million - $2.38 Million
-3,942 Reduced 10.73%
32,787 $18.9 Million
Q4 2022

Feb 07, 2023

BUY
$484.71 - $571.37 $114,391 - $134,843
236 Added 0.65%
36,729 $20.2 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $3.27 Million - $3.89 Million
-6,442 Reduced 15.0%
36,493 $18.5 Million
Q2 2022

Aug 08, 2022

BUY
$500.9 - $612.21 $2.08 Million - $2.55 Million
4,162 Added 10.73%
42,935 $23.3 Million
Q1 2022

May 12, 2022

SELL
$524.0 - $644.92 $655,524 - $806,794
-1,251 Reduced 3.13%
38,773 $22.9 Million
Q4 2021

Feb 02, 2022

BUY
$569.0 - $667.24 $283,362 - $332,285
498 Added 1.26%
40,024 $26.7 Million
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $2.38 Million - $2.84 Million
-4,663 Reduced 10.55%
39,526 $22.6 Million
Q2 2021

Aug 03, 2021

BUY
$441.0 - $508.24 $655,767 - $755,752
1,487 Added 3.48%
44,189 $22.3 Million
Q1 2021

May 10, 2021

SELL
$439.85 - $518.83 $5.93 Million - $6.99 Million
-13,481 Reduced 23.99%
42,702 $19.5 Million
Q4 2020

Feb 11, 2021

SELL
$435.06 - $527.66 $2.6 Million - $3.16 Million
-5,980 Reduced 9.62%
56,183 $26.2 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $5.64 Million - $6.92 Million
-15,672 Reduced 20.13%
62,163 $27.4 Million
Q2 2020

Aug 11, 2020

SELL
$275.2 - $362.34 $510,771 - $672,503
-1,856 Reduced 2.33%
77,835 $28.2 Million
Q1 2020

May 08, 2020

SELL
$255.3 - $340.05 $622,676 - $829,381
-2,439 Reduced 2.97%
79,691 $22.6 Million
Q4 2019

Feb 07, 2020

SELL
$271.93 - $328.04 $965,623 - $1.16 Million
-3,551 Reduced 4.14%
82,130 $26.7 Million
Q3 2019

Oct 31, 2019

BUY
$268.46 - $305.43 $315,977 - $359,491
1,177 Added 1.39%
85,681 $25 Million
Q2 2019

Aug 09, 2019

SELL
$257.51 - $295.55 $622,916 - $714,935
-2,419 Reduced 2.78%
84,504 $24.8 Million
Q1 2019

Apr 24, 2019

SELL
$212.17 - $273.72 $85,292 - $110,035
-402 Reduced 0.46%
86,923 $23.8 Million
Q4 2018

Jan 29, 2019

SELL
$208.47 - $251.98 $1.02 Million - $1.23 Million
-4,901 Reduced 5.31%
87,325 $19.5 Million
Q3 2018

Oct 26, 2018

SELL
$205.57 - $244.32 $401,889 - $477,645
-1,955 Reduced 2.08%
92,226 $22.5 Million
Q2 2018

Aug 10, 2018

SELL
$203.14 - $219.53 $57,285 - $61,907
-282 Reduced 0.3%
94,181 $19.5 Million
Q1 2018

May 01, 2018

BUY
$192.98 - $224.11 $2.17 Million - $2.52 Million
11,255 Added 13.53%
94,463 $19.5 Million
Q4 2017

Feb 07, 2018

SELL
$182.03 - $200.37 $95,929 - $105,594
-527 Reduced 0.63%
83,208 $15.8 Million
Q3 2017

Nov 09, 2017

BUY
$171.74 - $194.04 $14.4 Million - $16.2 Million
83,735
83,735 $15.8 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.